Logo
Patrys Investor Hub

Dr Samantha South's Interview with KapitaList - Part 1

Dr Samantha South, Patrys' CEO, talks with KapitaList about the benefits of reformulating an existing drug compared to developing new formulations.

This is Part 1, with Part 2 coming soon

Share your feedback

Discover